New HIV Vaccine Shows Unprecedented Success in Preclinical Study - POZ
New HIV Vaccine Shows Unprecedented Success in Preclinical Study POZScripps Research scientists train the immune system to make antibodies against numerous HIV strains Scripps ResearchTrain the cell, then deploy: Science behind the new HIV study, and why it's a foothold, not a finish line Hindustan TimesA new HIV vaccine offers hope for eliminating the disease — plus more medical headlines MSNGermline‑Targeting HIV Vaccine Generates Broadly Neutralizing Antibodies in Primates Genetic Engineering and Biotechnology News
